RxSight Inc.

15.74
-0.47 (-2.90%)
At close: Apr 04, 2025, 2:50 PM

RxSight Statistics

Share Statistics

RxSight has 40.49M shares outstanding. The number of shares has increased by 3.87% in one year.

Shares Outstanding 40.49M
Shares Change (YoY) 3.87%
Shares Change (QoQ) 0.46%
Owned by Institutions (%) 88.75%
Shares Floating 38.39M
Failed to Deliver (FTD) Shares 47
FTD / Avg. Volume 0.01%

Short Selling Information

The latest short interest is 2.28M, so 5.66% of the outstanding shares have been sold short.

Short Interest 2.28M
Short % of Shares Out 5.66%
Short % of Float 5.96%
Short Ratio (days to cover) 2.91

Valuation Ratios

The PE ratio is -48.67 and the forward PE ratio is 236.09. RxSight's PEG ratio is 0.98.

PE Ratio -48.67
Forward PE 236.09
PS Ratio 9.55
Forward PS 2.2
PB Ratio 4.75
P/FCF Ratio -59.69
PEG Ratio 0.98
Financial Ratio History

Enterprise Valuation

Currently the Enterprise Value (EV) is not available for RxSight.

EV / Sales n/a
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 11.36, with a Debt / Equity ratio of 0.04.

Current Ratio 11.36
Quick Ratio 10.5
Debt / Equity 0.04
Debt / EBITDA -0.52
Debt / FCF -0.55
Interest Coverage -1755.14

Financial Efficiency

Return on Equity is n/a and Return on Invested Capital is n/a.

Return on Equity n/a
Return on Assets n/a
Return on Invested Capital n/a
Revenue Per Employee $280.98K
Profits Per Employee $-55.13K
Employee Count 498
Asset Turnover 0.44
Inventory Turnover 1.86

Taxes

Income Tax 50K
Effective Tax Rate -0.18%

Stock Price Statistics

The stock price has increased by -68.44% in the last 52 weeks. The beta is 1.22, so RxSight's price volatility has been higher than the market average.

Beta 1.22
52-Week Price Change -68.44%
50-Day Moving Average 28.49
200-Day Moving Average 42.65
Relative Strength Index (RSI) 20.92
Average Volume (20 Days) 615.29K

Income Statement

In the last 12 months, RxSight had revenue of 139.93M and earned -27.45M in profits. Earnings per share was -0.71.

Revenue 139.93M
Gross Profit 98.94M
Operating Income -36.86M
Net Income -27.45M
EBITDA -23.76M
EBIT -27.38M
Earnings Per Share (EPS) -0.71
Full Income Statement

Balance Sheet

The company has 16.71M in cash and 12.3M in debt, giving a net cash position of 4.41M.

Cash & Cash Equivalents 16.71M
Total Debt 12.3M
Net Cash 4.41M
Retained Earnings -622.1M
Total Assets 318.56M
Working Capital 267.95M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -16.95M and capital expenditures -5.44M, giving a free cash flow of -22.39M.

Operating Cash Flow -16.95M
Capital Expenditures -5.44M
Free Cash Flow -22.39M
FCF Per Share -0.58
Full Cash Flow Statement

Margins

Gross margin is 70.71%, with operating and profit margins of -26.34% and -19.62%.

Gross Margin 70.71%
Operating Margin -26.34%
Pretax Margin -19.59%
Profit Margin -19.62%
EBITDA Margin -16.98%
EBIT Margin -26.34%
FCF Margin -16%

Dividends & Yields

RXST does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Payout Ratio n/a
Earnings Yield n/a
FCF Yield n/a
Dividend Details

Analyst Forecast

The average price target for RXST is $43, which is 162% higher than the current price. The consensus rating is "Buy".

Price Target $43
Price Target Difference 162%
Analyst Consensus Buy
Analyst Count 9
Stock Forecasts

Scores

Altman Z-Score 14.88
Piotroski F-Score 4